Skip to main content
. 2019 Sep 5;17:303. doi: 10.1186/s12967-019-2051-8

Fig. 2.

Fig. 2

Comparison between the groups of patients with detectable versus undetectable baseline ctDNA for OS and PFS. Kaplan–Meier curve for overall survival (a) and progression-free survival (b) according to ctDNA levels at baseline (pretreatment)—detectable versus undetectable